Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Randomized, Double-blind, Multiregional Phase 3 Study of Ivonescimab Combined with Chemotherapy Versus Pembrolizumab Combined with Chemotherapy for the First-line Treatment of Metastatic Non-small Cell Lung CancerHARMONi-3
Study Type: Treatment
Phase: III
NCTID: NCT05899608
Principal Investigator:
Chao Huang
A Phase 1/2 Study to Assess BDTX-1535, an Oral EGFR Inhibitor, in Patients with Glioblastoma or Non-Small Cell Lung Cancer
Prospective, Interventional Pilot Study of Mobile Devices and Digital Applications to Detect Early Pneumonitis and Other Pulmonary Adverse Events Causing Treatment Discontinuations in Unresectable Stage III Non-Small Cell Lung Cancer Patients on Durvalumab
Pivotal, Open-Label, Randomized Study Of Radiosurgery With Or Without Tumor Treating Fields TTFields For 1-10 Brain Metastases From Non-Small Cell Lung Cancer NSCLC.
A Randomized Phase II Study of Tepotinib with or without Ramucirumab in Participants with MET Exon 14 Skipping Positive Stage IV or Recurrent Non-Small Cell Lung Cancer Lung-MAP Sub-Study
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance for Small Cell Lung Cancer
Pre-Operative Immuno-Modulatory SBRT POIMS Trial: A pilot trial in early stage NSCLC
Study Type: Treatment
Phase: Feasibility/Pilot
NCTID: NCT05094544
Principal Investigator:
Shalina Gupta-Burt
Using Microbiome to Predict Durvalumab Toxicity in Post-CCRT NSCLC Patients MicroDurva
Study Type: Basic Science
Phase: IV
NCTID: NCT04680377
Principal Investigator:
Jun Zhang